Background and Purpose-Previous studies have shown that the ␤-amyloid precursor protein (␤APP) is upregulated after cerebral ischemia and that the ␤-amyloid (A␤) fragment may be toxic to brain cells. Although stroke in humans usually afflicts the elderly, most experimental studies on the nature of cerebral ischemia have used young animals. To test the hypothesis that the upregulation and/or persistence of amyloidogenic proteins is exacerbated in aged rats after cerebral ischemic stroke, we studied the expression of ␤APP and its proteolytic product A␤ in the brains of young and old rats 7 days after temporary cerebral ischemia. Methods-Focal cerebral ischemia was produced by reversible occlusion of the right middle cerebral artery in 3-and 20-month-old male Sprague-Dawley rats. After 1 week, brains were removed and immunostaining was performed for ␤APP, A␤, and ED1 for macrophages and glial fibrillary acidic protein (GFAP). Results-Histological staining revealed that the degree of necrotic cavitation in the infarct core was relatively less in aged rats than in young rats, suggesting a slower pace of degenerative change and/or tissue removal in older animals. ␤APP immunoreactivity was robustly increased, primarily in macrophage-like, ED1-positive cells in the infarct core and in the penumbra of both young and aged animals. A␤ immunoreactivity was evident in GFAP-positive astrocytic somata and processes, and also in clusters of small spherical structures in the penumbra. These A␤-immunoreactive minispheres were more numerous in aged rats than in young rats. Conclusions-The presence of ␤APP and A␤ immunoreactivity in the infarct core and penumbra indicates that cerebral ischemia promotes conditions that are favorable to the focal accumulation of ␤APP and its proteolytic fragments, especially in the aged brain. (Stroke. 1998;29:2196-2202.)
I
schemic stress increases intra-axonal ␤-amyloid precursor protein (␤APP) 1 levels and promotes the deposition of ␤-amyloid (A␤) in the human brain. 2 In rodents, ␤APP expression is increased in the brain after cerebral ischemia, [3] [4] [5] and there is evidence for the accumulation of A␤ as well. 6 Kalaria et al 3 showed that at 4 and 7 days postocclusion, ␤APP immunoreactivity is preferentially localized within axonal swellings, dystrophic neurites, and neuronal perikarya along the periphery of the infarct.
Substantial evidence suggests that ␤APP is involved in the regulation of neuronal growth and survival. Alternative processing of ␤APP can result in the production of the secreted forms of ␤APP (␤APPs), which may enhance neuronal plasticity and viability, or the A␤ peptide and C-terminal segment of ␤APP, which can be neurotoxic. Intrathecal administration of a 17-mer peptide of ␤APP, 20 minutes before ischemia and once daily for 3 days thereafter, has been
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shown to significantly reduce neurological damage. 7, 8 Furthermore, postischemic administration of ␤APPs intracerebroventricularly protects neurons in the CA1 region of rat hippocampus against ischemic injury.
9
On the other hand, cultured neuroblastoma cells degenerate around the infusion site of aggregated A␤ 1-40, 10 and intracerebral injections of A␤ have been shown to be neurotoxic in aged primates. 11 Furthermore, conditional expression of the carboxyl-terminal portion of ␤APP by using a tetracycline-responsive promoter system in neuroblastoma cells results in pronounced cytotoxicity. 12 Recent evidence derived from mice expressing the 100 -amino acid carboxyterminal fragment of ␤APP indicates that this fragment may promote synaptic degeneration and neuronal death. 13, 14 Likewise, there is an accumulation of the cytotoxic fragment of ␤APP in the hippocampus 7 days after global forebrain ischemia. 15 Notably, this process is accelerated with increasing age.
14 Although the incidence of ischemic stroke increases dramatically with advancing age, 16, 17 relatively few studies have been conducted on aged animals, which would mimic most closely the context in which stroke occurs in humans. We hypothesized that the upregulation and/or persistence of amylogenic proteins would be greater in aged rats than in young rats after cerebral ischemic stroke. To test this hypothesis, we studied the expression of ␤APP and its proteolytic product A␤ in the brains of 3-and 20-month-old rats 7 days after temporary occlusion of the middle cerebral artery.
Materials and Methods
The experiments reported in this study were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (NIH publication 93-23, revised 1985) , according to the recommendations of Gärtner, 18 and were approved by a federal animal care committee. Eighteen hours before surgery, male Sprague-Dawley rats (nϭ13 for each age group) were deprived of food to minimize variability in ischemic damage that can result from varying plasma glucose levels. 19 Water remained available at all times. In all cases, surgery was performed between 8 AM and 1 PM.
Reversible Occlusion of the Middle Cerebral Artery
Blood flow through the middle cerebral artery was temporarily interrupted using a modification of the method originally described by Brint et al, 20 Dirnagl et al, 21 and Zhang and Iadecola. 22 Throughout surgery, anesthesia was maintained by spontaneous inhalation of 1% to 1.5% halothane in a mixture of 75% nitrous oxide and 25% oxygen through a specially designed mask. Body temperature was kept at 37°C by a Homeothermic Blanket System (Harvard Apparatus). The anesthetized animals were immobilized in a supine position and the tail artery catheterized with PP50 tubing (IDϭ0.58 mm). This catheter enabled the continuous measurement of blood pressure and the withdrawal of blood samples for determination of pH and blood gases (Blutgassystem IL 1620; Instrumentation Laboratory) and arterial glucose levels (Omnican7 Balance; B. Braun, Melsungen). Under a surgical microscope, the left and right common carotid arteries were exposed and each loosely encircled with a silicon thread to facilitate the temporary closure of these vessels (see below).
The animals were placed in a prone position and the right lateral skull surface surgically exposed. Using a microdrill (Fine Science Tools), a small segment of the skull above the middle cerebral artery was removed 2-to 3-mm rostral to the juncture of the zygomatic arch and the pars squamosa of the temporal bone. The bone was thinned using a low drill speed and superfusion with physiological saline to minimize friction-induced warming. The bone flap was carefully removed with forceps and the underlying dura opened with a fine needle. The middle cerebral artery was then slowly lifted with a tungsten hook attached to a micromanipulator (Maerzhaeuser Precision Micro-manipulator Systems; Fine Science Tools) until blood flow through the artery was completely interrupted. Blood flow through the common carotid arteries was then stopped by tightening the prepositioned thread loops (see above). The surgical field was kept warm and moist with artificial cerebrospinal fluid (Liquicheck, Spinal Fluid Control, Bio-Rad) for the duration of the procedure.
Three hours later, the middle cerebral artery and the common carotid arteries were reopened, allowing full reperfusion of the brain. The surgical wounds were sutured shut, the catheter withdrawn from the tail artery and the animals returned to their cages. After a 7-day survival time, the rats were deeply anesthetized with 2.5% halothane in 75% nitrous oxide and 25% oxygen and perfused with buffered saline followed by buffered 4% freshly depolymerized paraformaldehyde. The brain was removed, postfixed in 4% buffered paraformaldehyde for 24 hours, cryoprotected in 20% sucrose prepared in 10 mmol/L phosphate-buffered saline (PBS), flash-frozen in isopentane, and stored at Ϫ70°C until sectioned.
Determination of Infarct Volume
The area and partial volume of every 20th section of the ipsilateral cerebral hemisphere and infarct site were measured stereologically. An integration of the resulting partial volumes provided the volume of the ipsilateral hemisphere along with the volume of the cortical infarct, which was then expressed as percent of the total volume of the hemisphere.
Histology
The brains were cut on a freezing-cold microtome, and 25-m-thick coronal sections were collected in 4% paraformaldehyde in 100 mmol/L PBS, pH 7.2, postfixed for 30 minutes, immersed in polyethylene glycol, and stored at Ϫ20°C until use.
Every 20th section was stained using acid-vanadium-fuchsin to detect neuronal degeneration. 23 In normal neuronal tissue, the nuclei are stained blue and the cytoplasm is light pink or unstained, whereas in the infarcted tissue, nuclei stain bright pink and are sometimes surrounded by a pink cytoplasm.
Immunocytochemistry
Free-floating sections were first treated with 0.3% hydrogen peroxide in PBS to inactivate endogenous peroxidase and then were processed for immunocytochemistry. After blocking in 3% donkey serum/10 mmol/L PBS/0.3% Tween 20, sections were incubated overnight at 4°C with monoclonal mouse antibodies recognizing either (1) the N-terminal epitope of ␤APP (clone 22C11, Boehringer Mannheim), (2) the cytoplasmic carboxyl fragment 643-695 of ␤APP (clone 2.F2.19B4, Boehringer Mannheim), (3) a cytoplasmic determinant of brain macrophages (clone ED1, Camon); or (4) the astrocytic marker glial fibrillary acidic protein (GFAP) (clone G-A-5, Boehringer Mannheim), diluted 1:800 in PBS containing 3% normal donkey serum and 0.3% Tween 20. The primary antibody was detected using the ABC system (Vectastain Elite Kit, Vector, ). After extensive washing in PBS containing 0.3% Tween 20, sections were incubated overnight at 4°C with biotinylated donkey antimouse IgG (Jackson ImmunoResearch Laboratories) and diluted 1:400 in PBS containing 1% normal donkey serum and 0.3% Tween 20. After washing in PBS, sections were incubated for 2 hours at room temperature in ABC Elite reagent diluted 1:100 in PBS containing 0.3% Tween 20. The antibody complex was then visualized with 0.025% 3Ј,3Ј diaminobenzidine and 0.005% hydrogen peroxide in 100 mmol/L Tris buffer (pH 7.5) for 5 to 10 minutes. Finally, the sections were mounted onto slides, air-dried, and placed on coverslips using a xylene-based mounting medium. For doublelabeling experiments, the sections were first incubated with the primary antibody and then by secondary antibodies conjugated with alkaline phosphatase. For color development, we used the nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate system (dark blue). After brief fixation, sections were further incubated with the second primary antibody followed by secondary biotinylated antibodies. Color development ensued using diaminobenzidine (brown) for the second antigen.
The specificity of the antibodies was verified by Western blot analysis and by omission of the primary antibodies in immunocytochemical experiments. For A␤ immunochemistry, specificity was further assessed by preincubation of the primary antibody with an excess of the A␤ peptide (Sigma).
Results
Twenty-four hours after surgery, the clinical status of the animals was assessed using the Bederson test. 24 At this time, all animals that had undergone cerebral ischemia for 3 hours showed obvious neurological deficits, including paresis of the contralateral extremities, particularly the hindlimbs, and rotation when lifted above the cage floor (grade 3 in the Bederson test, except for 1 young rat and 1 old rat that were scored as grade 2). Control animals showed no neurological deficits (grade 0). In the first 24 hours after surgery, the animals were somewhat listless, probably in part due to the aftereffects of the anesthesia. This condition improved to some extent in the ensuing days, although the animals tended to remain sensitive to external stimulation and noises. There was no evident difference in the clinical status of young and aged rats during the 7-day postsurgical survival time. Although the blood parameters showed some age-associated differences, notably in blood pressure, the differences were not statistically significant (Table) . Likewise, there was no significant difference in the volume of cortical infarcts between young and aged rats (42.7Ϯ11.4% for the young rats and 43.9Ϯ11.3% for the aged rats).
Histology
Acid-vanadium-fuchsin staining revealed age-related differences in the viability of cells in and around the infarct core. Within the infarct core of young animals, necrosis of the tissue progresses to cavitation ( Figure 1A ), whereas in older animals the degree of removal of necrotic tissue was reduced ( Figure 1B) . Likewise, the intensity of acid-vanadiumfuchsin staining of necrotic cells in the penumbra was greater in young animals ( Figure 1C ) than in aged animals ( Figure  1D ). Within the infarct core of older rats, some neuronal debris, most notably degenerating axons as revealed with antibodies against neurofilament-68, could still be discerned 7 days after ischemia (not shown).
Glial Fibrillary Acidic Protein
In the region surrounding the infarct core (penumbra) of young animals, the GFAP antibody revealed numerous hypertrophic astrocytes with long, profuse processes ( Figure  1E ); in the corresponding region of older animals, there were many reactive astrocytes as well, but the cells had shorter and thicker processes than in the young rats ( Figure 1F ), suggesting a more advanced reactive phenotype (Jorgensen et al, unpublished data, 1993).
A␤, ␤APP, and ED1
In both young and aged rats, A␤-immunoreactivity was associated with cells in the penumbra that have an astrocytic morphology (Figure 2A and B) . However, the reactive phenotype of A␤-positive astrocytes was more pronounced in old rats than in young rats ( Figure 2B) . A double-labeling experiment using antibodies to A␤ and GFAP confirmed that the A␤-immunoreactive cells are astrocytes (Figure 2A, inset) . In addition, small spherical objects that were immunopositive for A␤ were observed, most commonly in the penumbra of aged rats ( Figure 2B, inset) . Although these minispheres resembled some of the small dots seen with ␤APP and ED1 antibodies (see below), the A␤ spheres were fewer in number and tended to occur in clusters. Whether the antibody to A␤ is recognizing the cleaved A␤ peptide or the exposed epitope on holo-␤APP or fragmented ␤APP remains to be determined.
Using a monoclonal antibody against the cytoplasmic carboxyl fragment 643-695 of ␤APP, we found that ␤APP-immunostaining was associated primarily with cells that had a rounded morphology in both young and aged rats ( Figure  2C, 2D, insets) . In sections counterstained with hematoxylin, these immunoreactive cells resembled reactive macrophages, and some of them had the appearance of foam cells and multinucleated giant cells (not shown). In addition, numerous ␤APP-positive punctate structures of various sizes were scattered among the larger immunoreactive somata. The abundant ␤APP staining circumscribed the infarct core in which the necrotic tissue was still evident in the brains of many aged rats 7 days postischemia ( Figure 2D ). The ED1 antibody showed a staining pattern that was similar to that of ␤APP; ie, ED1-immunostaining was associated with rounded cells in the vicinity of the infarct core, with microglia-like cells in the penumbra and with numerous punctate structures ( Figure 2E and F and insets) . Double-immunostaining showed that the cells that contained ␤APP also were reactive with antibody ED1 (Figure 2E, insets) . Since ED1 is a marker for macrophages, we conclude that the ␤APP-positive cells are mainly macrophages derived from the brain and/or blood. 25, 26 We did not detect significant differences between the 2 age groups in the intensity or pattern of ␤APP and ED1 immunostaining.
Discussion
Our findings confirm previous studies showing that ␤APP is upregulated in the area of infarct after ischemic stroke. [1] [2] [3] [4] [5] [6] 27, 28 Immunocytochemical analysis revealed heavy staining of ␤APP epitopes at both the amino and the carboxyl ends of the molecule in large round cells, most probably macrophages derived from the blood and/or brain. A␤ immunostaining was more prominent in penumbral reactive astrocytes and especially in small spherical structures of older rats as compared with young rats, suggesting that the aged brain presents relatively favorable conditions for the focal accumulation of A␤. This is in line with other studies that have localized ␤APP by immunostaining to activated microglia 5 and to reactive astrocytes 5, 29 after ischemia in animal models. Data were obtained 20 minutes "before" and 20 minutes "after" middle cerebral artery occlusion. *One rat died, two rats had no infarct. **Three rats died.
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The persistence of necrotic tissue in the infarct core of aged animals at 7 days postischemia indicates that the degenerative process and/or glial removal of damaged tissue evolves at a slower pace in the infarcted area of aged rats than in that of young rats. These findings confirm a previous study in which the disintegration of injured brain tissue is considerably reduced in the ischemic area of aged rats, 30 apparently because of the diminished infiltration of the infarct site by macrophages. A slower rate of phagocytic removal of cellular debris in the aged brain might explain the presence of A␤-positive minispheres in the penumbra of our aged, but not young, animals. The same phenomenon may also account for the persistence and buildup of ␤-amyloid deposits in the brains of older humans. Such findings also are compatible with a shift from rapid necrosis in young neurons to delayed necrosis in aged neurons. 31 However, our data do not allow us Figure 1 . A through D, Acid-vanadium-fuchsin staining of coronal brain sections after cerebral ischemia. Note the relatively severe necrotic cavitation in the infarct core of 3-month-old rats (A) compared with the 20-month-old rats (B). Degenerating cells in the penumbra of 3-month-old rats (C, arrows) were more intensely stained than those in the penumbra of 20-month-old rats (D, arrows). E and F, Immunohistochemical staining of GFAP. Note the presence of numerous reactive astrocytes with profuse processes in the infarct penumbra of 3-month-old rats (E) versus astrocytes in 20-month-old rats, which had fewer, thicker processes (F). PE indicates penumbra; IC, infarct core. Bars: A, Bϭ250 m; C, Dϭ100 m; E, Fϭ50 m.
to distinguish between the delayed appearance of ischemic change in neurons that are destined to die and a delayed detrimental effect of ischemia on viable neurons. [31] [32] [33] [34] [35] However, given that ischemic neurons display enhanced acidophilia, 31 then it follows that the neurons from the young rats are in a more advanced state of ischemic degeneration than those from the old rats. Growing evidence suggests a synergistic and perhaps etiological link between vascular disease and Alzheimer's disease. In persons with numerous Alzheimer-like lesions, the arrows) and, to a lesser extent, in young (A) rats. A (inset), Double-labeling for A␤ and GFAP was especially evident in the cell bodies (dark color, arrows) and was less evident in processes, where GFAP labeling prevailed (dark blue, arrowheads). In the penumbra of old rats, clusters of small spherical A␤-positive structures were also apparent (B, inset, arrowheads). C and D, ␤APP was intensely immunostained in rounded cells and numerous small dots in the penumbra adjacent to the infarct core of young rats (C, inset, arrowheads) and old rats (D, inset, arrowheads). E and F, Immunohistochemical staining of ED1. Note the association of ED1 immunostaining with rounded cells circumscribing the infarct core as well as with microglia-like cells and punctate structures in the penumbra of both young (E) and old (F, insets) rats. Double-immunostaining revealed that the ␤APP-containing cells also were reactive with antibody ED1 (E, insets). PE indicates penumbra; IC, infarct core. Bars: A, B, C, D, and Fϭ50 m; insets, A, Eϭ18 m. expression of dementia is augmented by a history of stroke. 35 One means whereby stroke might promote the pathogenesis of Alzheimer's disease is through an upregulation of ␤APP. ␤APP responds to cerebral insult like an acute-phase protein 36 and therefore is likely to participate in the cellular response to brain insult. For example, head injury in humans is associated with an increased number of ␤APP-immunoreactive neurons, [37] [38] [39] as are other chronic and acute disorders of the central nervous system, including infarction. 1 Blood-derived cells also could be a significant source of ␤APP in ischemic brain regions. On stimulation, ␤APP is expressed by the major functional types of T lymphocytes, leukocytes, and peripheral blood monocytes. 40 The pathological accumulation of ␤APP after a variety of insults suggests a role for this protein in the central nervous system response to injury. [41] [42] [43] [44] [45] A 5-fold increase in A␤ has been reported for aged transgenic mice overexpressing the 695-amino acid isoform of human ␤PP containing a Lys6703 Asn, Met6713 Leu mutation 46 ; it would be interesting to determine whether overexpression of A␤ in these animals influences the response of the brain to ischemic stroke. The potential role of apolipoprotein E in the response of the brain to ischemia 28 also warrants further study, particularly in aged animals. A delayed response to damage in aged animals, in conjunction with the secretion of molecules having a deleterious effect on tissue regeneration, such as A␤, may explain, in part, the failure of older systems to recover function after cerebral ischemia.
